Via Afrika’s roots are from two publishing companies: Via Afrika, established in 1949 and Nasou, established in 1963. Via Afrika publishes a comprehensive range of educational materials for schools and FET Colleges in South Africa and Botswana. These publications include textbooks, readers, literature titles, atlases, study guides, wall charts and various teacher support materials for all grades and FET college levels. The company also has publishing experience in Namibia, Mozambique, and Zambia.
Since the introduction of the CAPS Curriculum, Via Afrika has been producing CAPS Curriculum textbooks in two ebook formats: EPUB for tablet computers and Flipbook for PC. Key to the development of these ebooks was the inclusion of multimedia and interactive enhancements that do not require internet connectivity for use.
Via Afrika partners with authors who are leading educationalists, including teachers, academics and Department of Education officials. This partnership enables Via Afrika to develop learning materials that make a difference. Via Afrika is also highly selective in the quality of freelancers and other service providers it contracts to add value to authors’ manuscripts.
Via Afrika was awarded the Sefika award for Best Educational Publisher of the year in South Africa for three consecutive years: 2011, 2012 and 2013. This annual award is made by the South African Booksellers Association (SABA) for the company that excels in aspects like service to customers, product training, promotional materials, turn-around times on orders and general product support.
Remaining true to its roots, Via Afrika outsources the printing, warehousing and distribution of all its materials to South African businesses.
Via Afrika is the trading name of Nasou Via Afrika Pty Ltd, (Registration number 1996/012379/07). Via Afrika’s ownership is made up of a 30% shareholding by Thebe Investment Holdings (Level 1 B-BBEE contributor) and a 70% shareholding by Media24 Books (Level 3 B-BBEE contributor).
Via Afrika is a Level 2 B-BBEE contributor.